The first Horizon Therapeutics Plc trade was made in Q2 2019.
Since then Jim Simons bought shares six more times and sold shares on twelve occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -3.43 Million shares
Q4 2023
Avg closing price
$116.18
Price range
$115.93
-
$116.30
Sold 0.4% shares (-15.4 Thousand shares)
Q3 2023
Avg closing price
$107.45
Price range
$98.98
-
$115.74
Increased shares by 2.4% (+80.3 Thousand shares)
Q2 2023
Avg closing price
$105.50
Price range
$96.34
-
$112.38
Increased shares by 101.1% (+1.69 Million shares)
Q1 2023
Avg closing price
$110.54
Price range
$107.32
-
$113.50
Increased shares by 7.3% (+114 Thousand shares)
Q4 2022
Avg closing price
$83.06
Price range
$61.58
-
$113.80
Sold 10.3% shares (-179 Thousand shares)
Q3 2022
Avg closing price
$69.87
Price range
$58.92
-
$84.67
Sold 14.1% shares (-286 Thousand shares)
Q2 2022
Avg closing price
$94.70
Price range
$79.40
-
$116.36
Sold 11.0% shares (-251 Thousand shares)
Q1 2022
Avg closing price
$97.45
Price range
$86.42
-
$109.81
Sold 30.0% shares (-974 Thousand shares)
Q4 2021
Avg closing price
$109.09
Price range
$98.56
-
$119.91
Sold 23.3% shares (-986 Thousand shares)
Q3 2021
Avg closing price
$103.81
Price range
$91.91
-
$110.37
Sold 18.7% shares (-972 Thousand shares)
Q2 2021
Avg closing price
$92.03
Price range
$86.24
-
$95.92
Sold 23.4% shares (-1.59 Million shares)
Q1 2021
Avg closing price
$84.39
Price range
$71.83
-
$95.48
Sold 22.6% shares (-1.98 Million shares)
Q4 2020
Avg closing price
$74.33
Price range
$67.00
-
$84.39
Sold 14.9% shares (-1.53 Million shares)
Q3 2020
Avg closing price
$68.81
Price range
$55.23
-
$79.93
Sold 2.9% shares (-311 Thousand shares)
Q2 2020
Avg closing price
$42.78
Price range
$30.20
-
$56.98
Increased shares by 5.2% (+523 Thousand shares)
Q1 2020
Avg closing price
$33.83
Price range
$24.87
-
$38.56
Increased shares by 8.0% (+750 Thousand shares)
Q4 2019
Avg closing price
$30.66
Price range
$25.43
-
$36.67
Increased shares by 6.8% (+596 Thousand shares)
Q3 2019